Eric Hsu
Vermögen: 3 $ am 31.05.2026
Vermögen: 3 $ am 31.05.2026
Eric C.
Hsu is Senior VP-Pre-Clinical Research & Development at InMed Pharmaceuticals, Inc. since 2018.
Formerly, Dr. Hsu was VP-Scientific Affairs, Research & Operations at enGene, Inc. from 2002 to 2018.
Education includes an undergraduate degree from McGill University and a doctorate from the University of Toronto conferred in 1999.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.12.2025 | 2 ( 0 % ) | 3 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 13.03.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Geschäftsführer | 01.01.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen